Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0006 Transporter Info
Gene Name	SLC22A2
Transporter Name	Organic cation transporter 2
Gene ID	6582
UniProt ID	O15244

Post-Translational Modification of This DT
Overview of SLC22A2 Modification Sites with Functional and Structural Information
Sequence	M P T T V D D V L E H G G E F H F F Q K Q M F F L L A L L S A T F A P I Y V G I V F L G F T P D H R C R S P G V A E L S L R C G W S P A E E L N Y T V P G P G P A G E A S P R Q C R R Y E V D W N Q S T F D C V D P L A S L D T N R S R L P L G P C R D G W V Y E T P G S S I V T E F N L V C A N S W M L D L F Q S S V N V G F F I G S M S I G Y I A D R F G R K L C L L T T V L I N A A A G V L M A I S P T Y T W M L I F R L I Q G L V S K A G W L I G Y I L I T E F V G R R Y R R T V G I F Y Q V A Y T V G L L V L A G V A Y A L P H W R W L Q F T V S L P N F F F L L Y Y W C I P E S P R W L I S Q N K N A E A M R I I K H I A K K N G K S L P A S L Q R L R L E E E T G K K L N P S F L D L V R T P Q I R K H T M I L M Y N W F T S S V L Y Q G L I M H M G L A G D N I Y L D F F Y S A L V E F P A A F M I I L T I D R I G R R Y P W A A S N M V A G A A C L A S V F I P G D L Q W L K I I I S C L G R M G I T M A Y E I V C L V N A E L Y P T F I R N L G V H I C S S M C D I G G I I T P F L V Y R L T N I W L E L P L M V F G V L G L V A G G L V L L L P E T K G K A L P E T I E E A E N M Q R P R K N K E K M I Y L Q V Q K L D I P L N
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	72
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC22A2 Asparagine 72 has the potential to affect its expression or activity.
Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the activity of SLC22A2			[2]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Iron	Results for Drug	Increasing uptake of iron
Modified Residue	Serine	Modified Location	43
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Serine 43 have been reported to enhance its transport activity.
PTM Phenomenon 2	Have the potential to influence SLC22A2			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	60
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Serine 60 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Serine 313 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC22A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Serine 317 has the potential to affect its expression or activity.
Tyrosine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the activity of SLC22A2			[5]
Role of PTM	Protein Activity Modulation
Modified Residue	Tyrosine
Related Enzyme	Tyrosine-protein kinase Yes (YES1)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Tyrosine have been reported to enhance its transport activity.
PTM Phenomenon 2	Substantially reduced the function of the transporter, without affecting its membrane expression			[5] , [6]
Role of PTM	Protein Activity Modulation
Modified Residue	Tyrosine	Modified Location	241
Modified State	Tyrosine to Phenylalanine mutation
Related Enzyme	Tyrosine-protein kinase Yes (YES1)
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Experimental Material(s)	Human papillomavirus-related endocervical adenocarcinoma (HeLa) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC22A2 Tyrosine 241 (i.e. Tyrosine to Phenylalanine mutation) have been reported to substantially reduced the function of the transporter, without affecting its membrane expression.
PTM Phenomenon 3	Impairing the function of SLC22A2			[5] , [6]
Role of PTM	Protein Activity Modulation
Modified Residue	Tyrosine	Modified Location	362
Modified State	Tyrosine to Phenylalanine mutation
Related Enzyme	Tyrosine-protein kinase Yes (YES1)
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Experimental Material(s)	Human papillomavirus-related endocervical adenocarcinoma (HeLa) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC22A2 Tyrosine 362 (i.e. Tyrosine to Phenylalanine mutation) have been reported to impaire its transport function.
PTM Phenomenon 4	Substantially reduced the function of the transporter, without affecting its membrane expression			[5] , [6]
Role of PTM	Protein Activity Modulation
Modified Residue	Tyrosine	Modified Location	377
Modified State	Tyrosine to Phenylalanine mutation
Related Enzyme	Tyrosine-protein kinase Yes (YES1)
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Experimental Material(s)	Human papillomavirus-related endocervical adenocarcinoma (HeLa) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC22A2 Tyrosine 377 (i.e. Tyrosine to Phenylalanine mutation) have been reported to substantially reduce its transport function, without affecting its membrane expression.
PTM Phenomenon 5	Have the potential to influence SLC22A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A2 Tyrosine 544 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S22A2_HUMAN)
2	Regulation of divalent metal transporter-1 by serine phosphorylation. Biochem J. 2016 Nov 15;473(22):4243-4254.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	The Clathrin-dependent Spindle Proteome. Mol Cell Proteomics. 2016 Aug;15(8):2537-53.
5	A phosphotyrosine switch regulates organic cation transporters. Nat Commun. 2016 Mar 16;7:10880.
6	Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res. 2016 Aug;110:89-95.
7	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
8	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence